FDA and EMA Compliant Pharmaceutical Manufacturing Facility

Designed to support regulated production, the facility offers powder, tablet and liquid manufacturing capabilities, including controlled production environments, laboratory and packaging areas, a USP purified-water system, high-capacity 480V three-phase power and centralized plant-style mechanical systems. Its functional, two-level configuration includes an 8,000-pound freight elevator, reinforced production floors, five dock doors and a warehouse with approximately 30-foot clear height. Select equipment and racking may also be available, providing a prospective user with the potential to shorten its path to production while avoiding the substantial cost and time required to replicate this specialized infrastructure.

A particularly compelling advantage is the potential availability of approximately 80 experienced employees from the existing operation. This established workforce possesses valuable knowledge in pharmaceutical manufacturing, quality, laboratory, packaging, maintenance and facility operations, giving an incoming company access to trained talent capable of supporting a faster and more efficient operational transition.

Supported by Central Iowa’s deep animal health, bioscience and advanced manufacturing ecosystem, the property combines specialized infrastructure, an experienced local workforce and a compelling cost-to-replacement proposition. For pharmaceutical, animal health, nutraceutical and other process-intensive users, 141 East Riverside Drive offers a distinctive opportunity to establish or expand operations within a proven manufacturing environment.

Available